delavirdine

Also known as U-90152, Rescriptor, (N-[2-[4-[3-(1-Methylethylamino)pyridin-2-yl]piperazin-1-yl]carbonyl-1H-indol-5-yl] methanesulfonamide), 1-(3-((1-Methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)piperazine, N-(2-(1-(3-(Isopropylamino)pyridin-2-yl)piperazine-4-carbonyl)-1H-indol-5-yl)methanesulfonamide, N-{2-[4-(3-isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide, 2-(4-(5-Methanesulfonamido-1H-indol-2-ylcarbonyl)-1-piperazinyl)-N-(1-methylethyl)-3-pyridinamine, Delavirdin

Delavirdine (DLV) (brand name Rescriptor) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that was marketed by ViiV Healthcare. It was used as part of highly active antiretroviral therapy (HAART) for the treatment of HIV-1 in the late 1990s and early 2000s. It is presented as the mesylate. The recommended dosage is 400 mg (as four 100-mg tablets or two 200-mg tablets) three times a day.

Chemical data

Formula: C22H28N6O3S
Molecular weight: 456.6 g/mol
IUPAC name: N-[2-[4-[3-(propan-2-ylamino)-2-pyridinyl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide
SMILES: CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C
InChIKey: WHBIGIKBNXZKFE-UHFFFAOYSA-N
XLogP: 2.4
Polar surface area: 119 Å²
H-bond donors: 3
H-bond acceptors: 7
Formal charge: 0

via PubChem

Wikidata facts

Mass: 456.194

Show 5 more facts

chemical formula: C₂₂H₂₈N₆O₃S
canonical SMILES: CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C
World Health Organisation international non-proprietary name: delavirdine
defined daily dose: 1.2
Commons category: Delavirdine

Sources (4)

via Wikidata · CC0

~4 min read

Article

4 sections

Contents

Interactions
Adverse effects
Synthesis
References

{{Drugbox | verifiedrevid = 460774806 | image = Delavirdine.svg | image_class = skin-invert-image | image2 = Delavirdine ball-and-stick model.png | image_class2 = bg-transparent | width = 250